| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/10/1995 | CA2182473A1 Co-administration of interleukin-3 mutants with colony stimulating factors |
| 08/09/1995 | EP0666315A1 Thrombocytestabilizing Factor-1X fragments, their preparation and use, and medicine containing them |
| 08/09/1995 | EP0665853A1 Multimeric polyvalent antithrombotic agents |
| 08/09/1995 | EP0665850A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 08/09/1995 | EP0535152B1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylene and piperazine compounds as PAF antagonists and compositions thereof. |
| 08/09/1995 | CN1106287A Blood nourishing granules |
| 08/08/1995 | US5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use |
| 08/08/1995 | US5439895 4-aminoquinazoline derivatives |
| 08/08/1995 | US5439894 Portion of hydroxyl groups of dextrin replaced by amine groups or residues; antacids |
| 08/08/1995 | US5439888 Antithrombotic agents |
| 08/08/1995 | US5439820 Anti-thrombin polypeptides |
| 08/08/1995 | US5439679 Peptide plasminogen activators |
| 08/08/1995 | US5439669 Biological imaging emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use |
| 08/08/1995 | US5439591 Feeding crude hemoglobin solution to column under anionic exchange conditions to bind more acidic components until column is overloaded and hemoglobin is displaced, feeding eluent to cationic column to bind more basic components |
| 08/03/1995 | WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
| 08/03/1995 | WO1995020399A1 Pharmaceutical compositions comprising hirudin |
| 08/03/1995 | WO1995014038A3 Purification of hemoglobin |
| 08/03/1995 | CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
| 08/03/1995 | CA2181907A1 Pharmaceutical compositions comprising hirudin |
| 08/03/1995 | CA2141642A1 Thrombocyte-stabilizing factor ix-fragments, their preparation and use and drugs containing these |
| 08/02/1995 | EP0665227A1 Polyhydronorharman synthase inhibitors |
| 08/02/1995 | EP0665019A1 Stable dry powders containing hirudin |
| 08/02/1995 | EP0664814A1 Lipopolysaccharide-binding and neutralizing peptides |
| 08/02/1995 | EP0664792A1 Fibrinogen receptor antagonists |
| 08/02/1995 | EP0664711A1 Peptide inhibitors of cellular adhesion |
| 08/02/1995 | CN1105989A Tricyclic 1-aminoethylpyrrol derivative |
| 08/02/1995 | CN1105988A 1-amino-ethylindole-derivatives |
| 08/02/1995 | CN1029404C Process for preparation of alpha-adrenergic receptor antagonists |
| 08/01/1995 | US5438041 Oxygen carrying multiple emulsions |
| 08/01/1995 | US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization |
| 08/01/1995 | CA2141231A1 6-azaindole thromboxane synthase inhibitors |
| 08/01/1995 | CA2140953A1 Polyhydronorharman synthase inhibitors |
| 08/01/1995 | CA1336514C Cyclo-octane neuroprotective agents |
| 08/01/1995 | CA1336501C Method of preventing or reducing venous thrombosis using a thromboxane a- receptor antagonist in conjunction with heparin and combination |
| 08/01/1995 | CA1336493C Pharmaceutically active combination of plasminogen activator and thrombin inhibitor |
| 07/27/1995 | WO1995019992A1 Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 07/27/1995 | WO1995019985A1 Haemopoietic maturation factor |
| 07/27/1995 | WO1995019952A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 07/27/1995 | WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/27/1995 | CA2181581A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 07/27/1995 | CA2181431A1 Haemopoietic maturation factor |
| 07/26/1995 | EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives |
| 07/26/1995 | EP0664126A1 Inhibition of thrombin |
| 07/26/1995 | EP0663918A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors |
| 07/26/1995 | EP0663829A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
| 07/26/1995 | CN1105800A Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
| 07/25/1995 | US5436343 Thromboxane A2 receptor antagonist, thromoboxane A2 synthase inhibitor |
| 07/25/1995 | US5436244 Antiarrhythmia agents |
| 07/25/1995 | US5436242 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation |
| 07/25/1995 | US5436233 Nervous system disorders |
| 07/25/1995 | US5436229 Bisulfite adducts of arginine aldehydes |
| 07/25/1995 | CA1336400C Method for treating renal diseases |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019176A1 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| 07/20/1995 | CA2158052A1 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| 07/19/1995 | EP0663009A1 High molecular weight desulphatohirudin |
| 07/19/1995 | EP0662950A1 Benzenealkanoic acids for cardiovascular diseases |
| 07/19/1995 | EP0662841A1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 07/19/1995 | EP0662782A1 Pp14-based therapy |
| 07/19/1995 | CN1105367A Glucosamine derivative, process for preparing the same and synthetic intermediate thereof |
| 07/19/1995 | CN1105254A Oral liquid for hypertension and hyperlipemia and preparing process thereof |
| 07/18/1995 | US5434150 Anticoagulants, cardiovascular disorders |
| 07/18/1995 | US5434073 Fibrinolytic and anti-thrombotic cleavable dimers |
| 07/18/1995 | US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin |
| 07/13/1995 | WO1995018858A1 Thrombopoietin |
| 07/13/1995 | WO1995018830A2 Inhibitors of human plasmin derived from the kunitz domains |
| 07/13/1995 | WO1995018619A1 Bicyclic fibrinogen antagonists |
| 07/12/1995 | EP0662513A1 Methods for preventing degradation of protein C |
| 07/12/1995 | EP0662138A1 Long wap promoter for mammary expression of human protein c |
| 07/12/1995 | EP0662088A1 Inhibitor of collagen-stimulated platelet aggregation |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0316319B1 Production and use of non-glycosylated IL-6 |
| 07/12/1995 | CN1105030A Erythropoietin analogs |
| 07/12/1995 | CN1105027A New compound, leustroducsin H, its preparation and its therapeutic use |
| 07/11/1995 | US5432189 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/11/1995 | CA1336269C Expression of mammalian genes at high levels in host cells |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018131A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995017907A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2180140A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | CA2177736A1 New ginkgolide derivatives and a process for preparing them |
| 07/05/1995 | EP0661541A2 Method of producing long time stable, clear serums |
| 07/05/1995 | EP0661051A2 Medicament for the treatment of perfusion changes |
| 07/04/1995 | US5430043 Platelet aggregation inhibitors |
| 07/04/1995 | US5430023 Tripeptide antithrombotic agents |
| 06/29/1995 | WO1995017397A1 Fibrinogen receptor antagonists |
| 06/29/1995 | WO1995017383A1 Indole derivatives as anti-estrogens |
| 06/29/1995 | WO1995017182A1 Protein kinase c inhibitors |
| 06/29/1995 | WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η? |
| 06/29/1995 | DE4345266A1 New isoquinolone or phthalazinone carboxylic acid ester and derivs. |
| 06/29/1995 | CA2187296A1 Indole derivatives as anti-estrogens |
| 06/29/1995 | CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma. |
| 06/28/1995 | EP0659427A1 2-Phenyl-3-azoylbenzothiophenes for increasing thombomodulin expression |
| 06/28/1995 | EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms |